Evidence map›Paper›PMID 23836566›Full record

ArticleThe American journal of tropical medicine and hygiene2013

Microgeographical differences of Plasmodium vivax relapse and re-infection in the Peruvian Amazon.

Raul Chuquiyauri, Pablo Peñataro, Kimberly C Brouwer, Manuel Fasabi, Maritza Calderon, Sonia Torres, Robert H Gilman, Margaret Kosek, Joseph M Vinetz

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Associations between weather andmedRxiv : the preprint server for health sciences · 2024
    Article
  3. Article
  4. Prospective Clinical and Molecular Evaluation of Potential Plasmodium ovale curtisi and wallikeri Relapses in a High-transmission Setting.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. Epidemiology of Plasmodium vivax Malaria in Peru.The American journal of tropical medicine and hygiene · 2016
    Article
  9. Accelerating to Zero: Strategies to Eliminate Malaria in the Peruvian Amazon.The American journal of tropical medicine and hygiene · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Raul ChuquiyauriDivision of Infectious Diseases, Department of Medicine, University of California San Diego, La Jolla, California 92093-0741, USA.
Pablo Peñataro
Kimberly C Brouwer
Manuel Fasabi
Maritza Calderon
Sonia Torres
Robert H Gilman
Margaret Kosek
Joseph M Vinetz
Johns Hopkins University · USPrisma · PEUniversity of California, San Diego · US

Funding

Sugar-feeding behavior of the malaria vector Nyssorhynchus darlingi and development of effective attractive toxic sugar baits (ATSB) to increase intervention success in PeruU19AI089681 · NIAID · YALE UNIVERSITY · PI VINETZ, JOSEPH M. · 2010 to 2023
$20.1M
University of California Launching Future Leaders in Global Health Research Training ProgramD43TW009343 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIG R COHEN, Sung-Jae Lee · 2017 to 2026
$14.7M
Human Reservoirs of Plasmodium vivax Transmission in the Peruvian AmazonR01AI067727 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VINETZ, JOSEPH M. · 2006 to 2010
$3.4M
Translational Research Development for Endemic Infectious Diseases of AmazoniaD43TW007120 · FIC · YALE UNIVERSITY · PI VINETZ, JOSEPH M. · 2004 to 2020
$3.0M
Patient-Oriented Research in Tropical Infectious DiseasesK24AI068903 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VINETZ, JOSEPH M. · 2006 to 2015
$1.5M
Global Health Partnership at UCSD and SDSUR25TW007500 · FIC · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2006 to 2009
$480k
FIC NIH HHS D43 TW007120FIC NIH HHS D43TW007120FIC NIH HHS D43 TW009343FIC NIH HHS R25 TW007500FIC NIH HHS R25TW007500Medical Research Council MR/K007467/1NIAID NIH HHS K24 AI068903NIAID NIH HHS K24AI068903NIAID NIH HHS R01 AI067727NIAID NIH HHS R01AI067727NIAID NIH HHS U19 AI089681NIAID NIH HHS U19AI089681
6 · The paper itself

Abstract

To determine the magnitude of Plasmodium vivax relapsing malaria in rural Amazonia, we carried out a study in four sites in northeastern Peru. Polymerase chain reaction-restriction fragment length polymorphism of PvMSP-3α and tandem repeat (TR) markers were compared for their ability to distinguish relapse versus reinfection. Of 1,507 subjects with P. vivax malaria, 354 developed > 1 episode during the study; 97 of 354 (27.5%) were defined as relapse using Pvmsp-3α alone. The addition of TR polymorphism analysis significantly reduced the number of definitively defined relapses to 26 of 354 (7.4%) (P < 0.05). Multivariate logistic regression modeling showed that the probability of having > 1 infection was associated with the following: subjects in Mazan (odds ratio [OR] = 2.56; 95% confidence interval [CI] 1.87, 3.51), 15-44 years of age (OR = 1.49; 95% CI 1.03, 2.15), traveling for job purposes (OR = 1.45; 95%CI 1.03, 2.06), and travel within past month (OR = 1.46; 95% CI 1.0, 2.14). The high discriminatory capacity of the molecular tools shown here is useful for understanding the micro-geography of malaria transmission.

Indexed as

Plasmodium vivaxAdolescentAdultChildChild, PreschoolDNA, ProtozoanFemaleGenetic MarkersGenotypeHumansMalaria, VivaxMaleMiddle AgedMolecular EpidemiologyPeruPolymerase Chain ReactionDNA, ProtozoanGenetic MarkersProtozoan Proteins

Identifiers

PMID23836566
PMCPMC3741256
OpenAlexW2147346978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.